APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gliflozin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025183 pages

Choose your research edition.

Industry ResearchGliflozin Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Gliflozin Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Gliflozin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gliflozin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gliflozin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Gliflozin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gliflozin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gliflozin include Janssen Pharmaceutical, Merck, Eli Lilly, Pfizer, AstraZeneca, Boehringer Ingelheim and Astellas Pharma Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gliflozin market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gliflozin and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gliflozin revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gliflozin market size, projected growth trends, production technologies, key applications, and end-use industries.

Gliflozin Segment by Company

Janssen Pharmaceutical

Merck

Eli Lilly

Pfizer

AstraZeneca

Boehringer Ingelheim

Astellas Pharma Inc.

Gliflozin Segment by Type

Dapagliflozin

Empagliflozin

Canagliflozin

Other

Gliflozin Segment by Application

Hospital

Clinic

Other

Gliflozin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliflozin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gliflozin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliflozin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gliflozin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gliflozin industry.

Chapter 3: Detailed analysis of Gliflozin companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gliflozinrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gliflozin Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Dapagliflozin Table 3. Key Players of Empagliflozin Table 4. Key Players of Canagliflozin Table 3. Key Players of Other Table 4. Global Gliflozin Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Gliflozin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gliflozin Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gliflozin Market Share by Region (2021-2026) Table 11. Global Gliflozin Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gliflozin Market Share by Region (2027-2032) Table 13. Gliflozin Industry Trends Table 14. Gliflozin Industry Drivers Table 15. Gliflozin Industry Opportunities and Challenges Table 16. Gliflozin Industry Restraints Table 17. Global Gliflozin Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gliflozin Revenue Market Share by Company (2021-2026) Table 19. Global Gliflozin Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gliflozin Key Company Head Office and Area Served Table 21. Global Gliflozin Company, Product Type & Application Table 22. Global Gliflozin Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gliflozin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gliflozin Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gliflozin Revenue Market Share by Type (2021-2026) Table 29. Global Gliflozin Revenue Market Share by Type (2027-2032) Table 30. Global Gliflozin Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gliflozin Revenue Market Share by Application (2021-2026) Table 34. Global Gliflozin Revenue Market Share by Application (2027-2032) Table 35. Janssen Pharmaceutical Company Information Table 36. Janssen Pharmaceutical Business Overview Table 37. Janssen Pharmaceutical Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Janssen Pharmaceutical Gliflozin Product Portfolio Table 39. Janssen Pharmaceutical Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Gliflozin Product Portfolio Table 44. Merck Recent Development Table 45. Eli Lilly Company Information Table 46. Eli Lilly Business Overview Table 47. Eli Lilly Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Eli Lilly Gliflozin Product Portfolio Table 49. Eli Lilly Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Gliflozin Product Portfolio Table 54. Pfizer Recent Development Table 55. AstraZeneca Company Information Table 56. AstraZeneca Business Overview Table 57. AstraZeneca Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AstraZeneca Gliflozin Product Portfolio Table 59. AstraZeneca Recent Development Table 60. Boehringer Ingelheim Company Information Table 61. Boehringer Ingelheim Business Overview Table 62. Boehringer Ingelheim Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Boehringer Ingelheim Gliflozin Product Portfolio Table 64. Boehringer Ingelheim Recent Development Table 65. Astellas Pharma Inc. Company Information Table 66. Astellas Pharma Inc. Business Overview Table 67. Astellas Pharma Inc. Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Astellas Pharma Inc. Gliflozin Product Portfolio Table 69. Astellas Pharma Inc. Recent Development Table 70. North America Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 71. North America Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 72. North America Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 73. North America Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 74. North America Gliflozin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Gliflozin Market Size by Country (2021-2026) Table 76. North America Gliflozin Market Size by Country (2027-2032) Table 77. Europe Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 78. Europe Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 79. Europe Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 80. Europe Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 81. Europe Gliflozin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. Europe Gliflozin Market Size by Country (2021-2026) Table 83. Europe Gliflozin Market Size by Country (2027-2032) Table 84. China Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 85. China Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 86. China Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 87. China Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 88. Asia Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 89. Asia Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 90. Asia Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 91. Asia Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 92. Asia Gliflozin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. Asia Gliflozin Market Size by Country (2021-2026) Table 94. Asia Gliflozin Market Size by Country (2027-2032) Table 95. South America, Middle East & Africa Gliflozin Market Size by Type (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Gliflozin Market Size by Type (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Gliflozin Market Size by Application (2021-2026) & (US$ Million) Table 98. South America, Middle East & Africa Gliflozin Market Size by Application (2027-2032) & (US$ Million) Table 99. South America, Middle East & Africa Gliflozin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. South America, Middle East & Africa Gliflozin Market Size by Country (2021-2026) Table 101. South America, Middle East & Africa Gliflozin Market Size by Country (2027-2032) Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Gliflozin Product Image Figure 2. Global Gliflozin Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gliflozin Market Share by Type: 2025 VS 2032 Figure 4. Dapagliflozin Image Figure 5. Empagliflozin Image Figure 6. Canagliflozin Image Figure 7. Other Image Figure 8. Global Gliflozin Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Gliflozin Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Gliflozin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gliflozin Market Size (2021-2032) & (US$ Million) Figure 15. Global Gliflozin Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Gliflozin Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Gliflozin Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gliflozin Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gliflozin Revenue Market Share by Type (2021-2032) Figure 22. Global Gliflozin Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gliflozin Revenue Market Share by Application (2021-2032) Figure 24. North America Gliflozin Market Size (2021-2032) & (US$ Million) Figure 25. North America Gliflozin Market Share by Type (2021-2032) Figure 26. North America Gliflozin Market Share by Application (2021-2032) Figure 27. North America Gliflozin Market Share by Country (2021-2032) Figure 28. United States Gliflozin Market Size (2021-2032) & (US$ Million) Figure 29. Canada Gliflozin Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Gliflozin Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gliflozin Market Size (2021-2032) & (US$ Million) Figure 32. Europe Gliflozin Market Share by Type (2021-2032) Figure 33. Europe Gliflozin Market Share by Application (2021-2032) Figure 34. Europe Gliflozin Market Share by Country (2021-2032) Figure 35. Germany Gliflozin Market Size (2021-2032) & (US$ Million) Figure 36. France Gliflozin Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Gliflozin Market Size (2021-2032) & (US$ Million) Figure 38. Italy Gliflozin Market Size (2021-2032) & (US$ Million) Figure 39. Russia Gliflozin Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Gliflozin Market Size (2021-2032) & (US$ Million) Figure 41. China Gliflozin Market Size (2021-2032) & (US$ Million) Figure 42. China Gliflozin Market Share by Type (2021-2032) Figure 43. China Gliflozin Market Share by Application (2021-2032) Figure 44. Asia Gliflozin Market Size (2021-2032) & (US$ Million) Figure 45. Asia Gliflozin Market Share by Type (2021-2032) Figure 46. Asia Gliflozin Market Share by Application (2021-2032) Figure 47. Asia Gliflozin Market Share by Country (2021-2032) Figure 48. Japan Gliflozin Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Gliflozin Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Gliflozin Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Gliflozin Market Size (2021-2032) & (US$ Million) Figure 52. India Gliflozin Market Size (2021-2032) & (US$ Million) Figure 53. Australia Gliflozin Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gliflozin Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Gliflozin Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Gliflozin Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Gliflozin Market Share by Country (2021-2032) Figure 58. Brazil Gliflozin Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Gliflozin Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Gliflozin Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Gliflozin Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Gliflozin Market Size (2021-2032) & (US$ Million) Figure 63. UAE Gliflozin Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Gliflozin Market Size (2021-2032) & (US$ Million) Figure 65. Chile Gliflozin Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Dapagliflozin
  • Empagliflozin
  • Canagliflozin
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Janssen Pharmaceutical
  • Merck
  • Eli Lilly
  • Pfizer
  • AstraZeneca
  • Boehringer Ingelheim
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gliflozin Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Dapagliflozin
  5. 1.2.3 Empagliflozin
  6. 1.2.4 Canagliflozin
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Gliflozin Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Gliflozin Growth Trends by Region
  15. 1.5.1 Global Gliflozin Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Gliflozin Market Size by Region (2021-2026)
  17. 1.5.3 Gliflozin Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Gliflozin Market Dynamics
  1. 2.1 Gliflozin Industry Trends
  2. 2.2 Gliflozin Industry Drivers
  3. 2.3 Gliflozin Industry Opportunities and Challenges
  4. 2.4 Gliflozin Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gliflozin Revenue by Company (2021-2026)
  2. 3.2 Global Gliflozin Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gliflozin Key Company Head office and Area Served
  4. 3.4 Global Gliflozin Company, Product Type & Application
  5. 3.5 Global Gliflozin Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gliflozin Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gliflozin Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gliflozin Tier 1, Tier 2, and Tier 3
4 Gliflozin Market by Type
  1. 4.1 Global Gliflozin Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gliflozin Market Size by Type (2021-2032)
  3. 4.3 Global Gliflozin Market Size Share by Type (2021-2032)
5 Gliflozin Market by Application
  1. 5.1 Global Gliflozin Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gliflozin Market Size by Application (2021-2032)
  3. 5.3 Global Gliflozin Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Janssen Pharmaceutical
  2. 6.1.1 Janssen Pharmaceutical Company Information
  3. 6.1.2 Janssen Pharmaceutical Business Overview
  4. 6.1.3 Janssen Pharmaceutical Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Janssen Pharmaceutical Gliflozin Product Portfolio
  6. 6.1.5 Janssen Pharmaceutical Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Gliflozin Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly Gliflozin Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer Gliflozin Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AstraZeneca Gliflozin Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Boehringer Ingelheim
  32. 6.6.1 Boehringer Ingelheim Company Information
  33. 6.6.2 Boehringer Ingelheim Business Overview
  34. 6.6.3 Boehringer Ingelheim Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Boehringer Ingelheim Gliflozin Product Portfolio
  36. 6.6.5 Boehringer Ingelheim Recent Developments
  37. 6.7 Astellas Pharma Inc.
  38. 6.7.1 Astellas Pharma Inc. Company Information
  39. 6.7.2 Astellas Pharma Inc. Business Overview
  40. 6.7.3 Astellas Pharma Inc. Gliflozin Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Astellas Pharma Inc. Gliflozin Product Portfolio
  42. 6.7.5 Astellas Pharma Inc. Recent Developments
7 North America
  1. 7.1 North America Gliflozin Market Size (2021-2032)
  2. 7.2 North America Gliflozin Market Size by Type
  3. 7.2.1 North America Gliflozin Market Size by Type (2021-2026)
  4. 7.2.2 North America Gliflozin Market Size by Type (2027-2032)
  5. 7.2.3 North America Gliflozin Market Share by Type (2021-2032)
  6. 7.3 North America Gliflozin Market Size by Application
  7. 7.3.1 North America Gliflozin Market Size by Application (2021-2026)
  8. 7.3.2 North America Gliflozin Market Size by Application (2027-2032)
  9. 7.3.3 North America Gliflozin Market Share by Application (2021-2032)
  10. 7.4 North America Gliflozin Market Size by Country
  11. 7.4.1 North America Gliflozin Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gliflozin Market Size by Country (2021-2026)
  13. 7.4.3 North America Gliflozin Market Size by Country (2027-2032)
  14. 7.4.4 North America Gliflozin Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gliflozin Market Size (2021-2032)
  2. 8.2 Europe Gliflozin Market Size by Type
  3. 8.2.1 Europe Gliflozin Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gliflozin Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gliflozin Market Share by Type (2021-2032)
  6. 8.3 Europe Gliflozin Market Size by Application
  7. 8.3.1 Europe Gliflozin Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gliflozin Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gliflozin Market Share by Application (2021-2032)
  10. 8.4 Europe Gliflozin Market Size by Country
  11. 8.4.1 Europe Gliflozin Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gliflozin Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gliflozin Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gliflozin Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gliflozin Market Size (2021-2032)
  2. 9.2 China Gliflozin Market Size by Type
  3. 9.2.1 China Gliflozin Market Size by Type (2021-2026)
  4. 9.2.2 China Gliflozin Market Size by Type (2027-2032)
  5. 9.2.3 China Gliflozin Market Share by Type (2021-2032)
  6. 9.3 China Gliflozin Market Size by Application
  7. 9.3.1 China Gliflozin Market Size by Application (2021-2026)
  8. 9.3.2 China Gliflozin Market Size by Application (2027-2032)
  9. 9.3.3 China Gliflozin Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gliflozin Market Size (2021-2032)
  2. 10.2 Asia Gliflozin Market Size by Type
  3. 10.2.1 Asia Gliflozin Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gliflozin Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gliflozin Market Share by Type (2021-2032)
  6. 10.3 Asia Gliflozin Market Size by Application
  7. 10.3.1 Asia Gliflozin Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gliflozin Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gliflozin Market Share by Application (2021-2032)
  10. 10.4 Asia Gliflozin Market Size by Country
  11. 10.4.1 Asia Gliflozin Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gliflozin Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gliflozin Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gliflozin Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gliflozin Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gliflozin Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gliflozin Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gliflozin Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gliflozin Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gliflozin Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gliflozin Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gliflozin Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gliflozin Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gliflozin Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gliflozin Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gliflozin Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gliflozin Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gliflozin Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst